| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| A0A023QJS4 | Cytochrome b; | CYTB; | NULL | 380 | human |
| B4YD74 | Cytochrome b; | CYTB; | NULL | 378 | human |
| D3DRD4 | Fibroblast growth factor receptor; EC 2.7.10.1; | FGFR2; | NULL | 724 | human |
| B4DK89 | cDNA FLJ60623, highly similar to tRNA isopentenyltransferase, mitochondrial; EC 2.5.1.8; tRNA dimethylallyltransferase, mitochondrial; | TRIT1; | NULL | 143 | human |
| C9D5R1 | NADH-ubiquinone oxidoreductase chain 4; EC 1.6.5.3; | ND4; | NULL | 459 | human |
| E5KMK5 | Mitochondrial DNA topoisomerase I; | NULL | NULL | 601 | human |
| B9TX21 | Mediator complex subunit MED16 variant MED16_i28; Mediator of RNA polymerase II transcription subunit 16; | MED16; | NULL | 135 | human |
| Q6R0X2 | NADH-ubiquinone oxidoreductase chain 1; EC 1.6.5.3; | ND1; | NULL | 318 | human |
| Q9H4C5 | E3 ubiquitin-protein ligase Mdm2; p53-binding protein; | MDM2; | NULL | 243 | human |
| A0SBN6 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
| X5C5Z6 | NADH-ubiquinone oxidoreductase chain 2; EC 1.6.5.3; | ND2; | NULL | 347 | human |
| Q6VIF8 | NADH-ubiquinone oxidoreductase chain 2; EC 1.6.5.3; | ND2; NADH2 ndh2; | NULL | 347 | human |
| A8QTM8 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
| C1K3N0 | Transcription factor AP-2 alpha; Transcription factor AP-2-alpha; | TFAP2A; | NULL | 328 | human |
| Q2LHC6 | NADH-ubiquinone oxidoreductase chain 2; EC 1.6.5.3; | ND2; | NULL | 347 | human |
| Q4GMK4 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | NADH5; ND5; | NULL | 603 | human |
| U3M2W8 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
| G9LFX9 | NADH-ubiquinone oxidoreductase chain 4; EC 1.6.5.3; | ND4; | NULL | 459 | human |
| A0A059S7J4 | Cytochrome b; | CYTB; | NULL | 380 | human |
| D0EV56 | MHC class II antigen; | HLA-DRB1; | NULL | 266 | human |
